Slide 1: Exchange filing cover letter: Investor Communication
^&^. ^^ Ref: SEC/SE/2023-24 Date: May 4, 2023 W£T India Ltd. To, Corporate Relation Department National Stock Exchange of India Ltd. BSE Ltd. Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C/l, G Block, Bandra Kurla Complex Dalal Street, Mumbai- 400001 Bandra (E), Mumbai -400051 BSE Sc
Slide 2: FY23 & Q4 FY23 Results Presentation
FY23 & Q4 FY23 Results Presentation 4th May 2023
Slide 3: Agenda
AGENDA 1 FY23 Performance Summary 2 Q4 FY23 – Performance Summary 3 FY23 & Q4 FY23 – Business Highlights 4 ESG & Dividend Update
Slide 4: Agenda
AGENDA 1 FY23 Performance Summary 2 Q4 FY23 – Performance Summary 3 FY23 & Q4 FY23 – Business Highlights 4 ESG & Dividend Update
Slide 5: FY23 - Performance Highlights
FY23 - Performance Highlights Consol Revenue crosses INR Consol Revenue Growth in Consol Revenue 3-year CAGR 11,000 cr to close FY23 at FY23 INR 11,530 cr 5.9% 10% India Business crosses 8,500 cr India Business Revenue Growth India Revenue 3-year CAGR to close the FY23 at in FY23 INR 8,684 cr 6.2% 1
Slide 6: FY23 – Consolidated Financials
FY23 – Consolidated Financials Revenue Operating Profit Reported PAT 3-year CAGR: 10% 3-year CAGR: 6.5% 3-year CAGR: 6% 20.7% 16.0% 18.8% 14.8% 11,530 10,889 2,254 2,164 1,739 1,707 6% (4%) (1.8%) FY22 FY23 FY22 FY23 FY22 FY23 Operating Profit (INR cr) PAT (INR cr) PAT Margin Op. Profit Margin • CC
Slide 7: FY23 – PAT before exceptional items and amortization
FY23 – PAT before exceptional items and amortization Consolidated Business Change FY22 FY23 % Profit after Minority (Reported) 1,739 1,707 (1.8%) Exceptional Items: Impairment of goodwill of wholly- owned subsidiary, M/s Hobi 0 85 Kozmetik Amortization: Amortization (impact on Net Profit 11 0 after
Slide 8: FY23 – Domestic FMCG Growth – By Verticals
FY23 – Domestic FMCG Growth – By Verticals Sales Contribution by Verticals FY22 FY23 Healthcare Home & Personal Care (HPC) Food & Beverage (F&B)* 3-year CAGR: 9% 3-year CAGR: 9% 3-year CAGR: 22% 2,772 2,645 2,581 3,846 3,657 1,724 3,245 2,006 2,964 1,326 946 891 32% 5% (7%) 9% 13% 5% (6%) 49% 30% FY
Slide 9: FY23 – International Business Performance
FY23 – International Business Performance Sales Contribution FY22 FY23 Others Others 2.3% 3.6% International International 26.0% 25.1% Domestic Domestic 71.7% 71.3% International Business grew by 11% in CC terms (2.2% in INR terms) FY23 Constant Currency Growth % 90.0% 28.4% 9.5% 10.7% (11.7%) (3.7%
Slide 10: Agenda
AGENDA 1 FY23 Performance Summary 2 Q4 FY23 – Performance Summary 3 FY23 & Q4 FY23 – Business Highlights 4 ESG & Dividend Update
Slide 11: Q4 FY23 – Consolidated Financials
Q4 FY23 – Consolidated Financials Revenue Operating Profit PAT 2,678 11.7% 11.2% 18.0% 2,518 15.3% 294 301 454 410 6.4% (9.6%) 2.2% Q4 FY22 Q4 FY23 Q4 FY22 Q4 FY23 Q4 FY22 Q4 FY23 Operating Profit (INR cr) PAT (INR cr) PAT Margin Op. Profit Margin • CC Growth of 8.6% • Consolidated Op Profit Margin
Slide 12: Q4 FY23 – PAT before exceptional items and amortization
Q4 FY23 – PAT before exceptional items and amortization Consolidated Business Q4 Q4 Change FY22 FY23 % Profit after Minority (Reported) 301 294 2.2% Exceptional Items: Impairment of goodwill of wholly- owned subsidiary, M/s Hobi 0 85 Kozmetik Amortization: Amortization (impact on Net Profit 11 0 aft
Slide 13: Agenda
AGENDA 1 FY23 Performance Summary 2 Q4 FY23 – Performance Summary 3 FY23 & Q4 FY23 – Business Highlights 4 ESG & Dividend Update
Slide 14: FY23 & Q4 FY23 | Business Highlights – Healthcare
FY23 & Q4 FY23 | Business Highlights – Healthcare Health Supplements Digestives OTC & Ethicals FY23 Growth % (12.4%) 10.4% (4.2%) FY23 : 3-year CAGR 8.1% 8.3% 12.3% Q4 FY23 Growth % (3.3%) 5.6% (0.4%) Q4 FY23 : 3-year CAGR 8.1% 8.6% 13.6% • Health Supplements lapping • The portfolio saw strong growt
Slide 15: FY23 & Q4 FY23 | Business Highlights – HPC
FY23 & Q4 FY23 | Business Highlights – HPC Home Care Oral Care Hair Oils Shampoo Skin Care FY23 23% 5% 1% 8% 4% Growth % ex-sanitize FY23 : 3-year CAGR 12% 12% 6% 15% 1% Q4 FY23 10.3% (3%) Flat 2% (2%) Growth % ex-sanitize Q4 FY23 : 3-year CAGR 15% 12% 8.5% 13% 2% • Robust double- • Toothpaste • Hai
Slide 16: FY23 & Q4 FY23 | Business Highlights – Food & Beverages
FY23 & Q4 FY23 | Business Highlights – Food & Beverages Beverages Foods FY23 Growth % 30% 28%* FY23 : 3-year CAGR 22% 20%* Q4 FY23 Growth % 29% 22%* Q4 FY23 : 3-year CAGR 30% 22%* • Beverage business continued to be on a strong • Hommade brand continued to perform well driven by trajectory innovatio
Slide 17: Agenda
AGENDA 1 FY23 Performance Summary 2 Q4 FY23 – Performance Summary 3 FY23 & Q4 FY23 – Business Highlights 4 ESG and Dividend Update
Slide 18: Dabur – Sustainably Yours
Dabur – Sustainably Yours Climate & Biodiversity Sustainable Sourcing Circular Economy • 100% of Tetra pack laminate and paper • 100% of DIL’s own operations are outside sourcing being done from FSC-certified • 100% Plastic positivity achieved in FY23 endangered Bio-diversity zones vendors. • 20% re
Slide 19: Dividend Update
Dividend Update Interim Dividend Final Dividend Total Dividend Dividend per share 2.50 2.70 5.20 (INR) Dividend % 250% 270% 520% Total Dividend (INR cr) 442.94 478.38 921.32 Dividend Payout Ratio* 54%
Slide 20: Summarised Financial Statements
Summarised Financial Statements
Slide 21: Consolidated Profit & Loss
Consolidated Profit & Loss Q4 FY23 Q4 FY22 Y-o-Y (%) FY23 FY22 Y-o-Y (%) Revenue from operations 2,677.8 2,517.8 6.4% 11,529.9 10,888.7 5.9% Other Income 120.7 99.1 21.8% 445.4 393.2 13.3% Total Income 2,798.5 2,616.9 6.9% 11,975.3 11,281.8 6.1% Material Cost 1,451.0 1,323.3 9.7% 6,268.7 5,639.7 11.
Slide 22: Consolidated Balance Sheet
Consolidated Balance Sheet As at As at As at As at Particulars 31/03/2023 31/03/2022 Particulars 31/03/2023 31/03/2022 (Audited) (Audited) (Audited) (Audited) A Assets B Equity and Liabilities 1 Non-current assets 1 Equity (a) Property, plant and equipment 2,238 1,968 (a) Equity share capital 177 17
Slide 23: Standalone Profit & Loss
Standalone Profit & Loss Q4 FY23 Q4 FY22 Y-o-Y (%) FY23 FY22 Y-o-Y (%) Revenue from operations 1,939.5 1,852.3 4.7% 8,684.3 8,179.5 6.2% Other Income 114.8 92.2 24.5% 392.2 341.6 14.8% Total Income 2,054.2 1,944.5 5.6% 9,076.5 8,521.1 6.5% Material Cost 1,081.6 1,019.3 6.1% 4,855.0 4,377.2 10.9% % o
Slide 24: Standalone Balance Sheet
Standalone Balance Sheet As at As at As at As at Particulars 31/03/2023 31/03/2022 Particulars 31/03/2023 31/03/2022 (Audited) (Audited) (Audited) (Audited) A Assets B Equity and Liabilities 1 Non-current assets 1 Equity (a) Property, plant and equipment 1,596 1,329 (a) Equity share capital 177 177
Slide 25: For more information and updates, visit Dabur investor page
For more information and updates, visit: http://www.Dabur.Com/in/en-us/investor